- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-6901
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nimodipine Pharmacokinetic Variability in Various Patient Populations ; day:9 ; month:9 ; year:2020 ; pages:1-12
Drugs in R & D ; (9.9.2020), 1-12
- Urheber
-
Mahmoud, Sherif Hanafy
Ji, Xinqi
Isse, Fadumo Ahmed
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40268-020-00322-3
- URN
-
urn:nbn:de:101:1-2020102919044090718217
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mahmoud, Sherif Hanafy
- Ji, Xinqi
- Isse, Fadumo Ahmed
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
Pharmacokinetic/pharmacodynamic-guided optimisation of monoclonal antibody therapy in special populations
Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxytol Plasma Pharmacokinetics Across Populations
Adaptation of human skin color in various populations
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Genetic variability in Italian populations of Drosophila suzukii
Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability
Physiologically based pharmacokinetic modeling of apixaban to predict exposure in populations with hepatic and renal impairment and elderly populations
Development of LC-MS methods for early stage pharmacokinetic evaluation of various bioactive compounds
Development and evaluation of a physiologically based pharmacokinetic model for populations of pregnant women
Hereditary myopathy with early respiratory failure: occurrence in various populations
A population pharmacokinetic model of cabozantinib in healthy volunteers and patients with various cancer types
Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
Pharmacokinetic/pharmacodynamic-guided optimisation of monoclonal antibody therapy in special populations
Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxytol Plasma Pharmacokinetics Across Populations
Adaptation of human skin color in various populations
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Genetic variability in Italian populations of Drosophila suzukii
Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability
Physiologically based pharmacokinetic modeling of apixaban to predict exposure in populations with hepatic and renal impairment and elderly populations
Development of LC-MS methods for early stage pharmacokinetic evaluation of various bioactive compounds
Development and evaluation of a physiologically based pharmacokinetic model for populations of pregnant women
Hereditary myopathy with early respiratory failure: occurrence in various populations
A population pharmacokinetic model of cabozantinib in healthy volunteers and patients with various cancer types
Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
Pharmacokinetic/pharmacodynamic-guided optimisation of monoclonal antibody therapy in special populations
Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxytol Plasma Pharmacokinetics Across Populations
Adaptation of human skin color in various populations
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
Genetic variability in Italian populations of Drosophila suzukii
Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability
Physiologically based pharmacokinetic modeling of apixaban to predict exposure in populations with hepatic and renal impairment and elderly populations
Development of LC-MS methods for early stage pharmacokinetic evaluation of various bioactive compounds
Development and evaluation of a physiologically based pharmacokinetic model for populations of pregnant women
Hereditary myopathy with early respiratory failure: occurrence in various populations